Mikio Murata

Prof. Dr. Mikio Murata

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Drones
Verified
Journal Article
Open access
PDF file
KYKoki Yakushiji
Koki Yakushiji
HFHiroshi Fujita
Hiroshi Fujita
MMMikio Murata
Mikio Murata
NHNaoki Hiroi
Naoki Hiroi
YHYuuichi Hamabe
Yuuichi Hamabe
FYFumiatsu Yakushiji
Fumiatsu Yakushiji
Larger types of small unmanned aerial vehicles (UAVs) are beginning to be used in the United States and Europe for commercial transportation. Additionally, some blood product transport systems have been commercialized in Rwanda and other countries and used in pandemic operations for the coronavirus disease 2019 (COVID-19) in infected areas. Conversely, implementing goods transportation for commercial purposes in Japan has been difficult, especially in urban areas, due to national legislation. This study examined UAV-assisted transportation in Japan, a natural disaster hotspot, with a focus on the potential uses of UAVs in situations where traffic blockages make ground transportation impossible. UAVs were used to transport 17 kg of medical supplies belonging to a disaster medical assistance team (DMAT), along with 100 emergency meals. We also transported insulin under controlled-temperature conditions, as well as many other emergency supplies. Using UAVs to transport emergency supplies could be an effective approach when dealing with disasters. This paper summarizes the effectiveness of this approach for medical care and disaster response activities. We present a method for using drones to bridge the gap between medical and firefighting personnel, such as DMAT personnel, who are engaged in life-saving activities at the time of a disaster, and those who are unable to transport necessary goods by land using terrestrial vehicles due to traffic interruptions.

22 January 2020 in Drones
Verified
Journal Article
Open access
PDF file
FYFumiatsu Yakushiji
Fumiatsu Yakushiji
KYKoki Yakushiji
Koki Yakushiji
MMMikio Murata
Mikio Murata
NHNaoki Hiroi
Naoki Hiroi
KTKeiji Takeda
Keiji Takeda
HFHiroshi Fujita
Hiroshi Fujita
Unmanned aerial vehicles (UAVs), or drones, are used in Rwanda for transfusion transport, but they have not yet been used in Japan. This technology holds promise for transporting medical supplies during disasters or to remote places where the terrain makes it difficult to travel by land. One of the difficulties in using UAVs is the temperature-control requirements for red blood cell (RBC) solutions, i.e., 2 °C to 6 °C according to Japanese regulations. This study aimed to describe the effectiveness of UAV-based transport of RBC solution. For testing, we gradually increased the UAV travel distance, monitored the temperature of the RBC solution, and conducted laboratory tests to check the integrity of the blood sample. Lactate dehydrogenase (LD) was used as a hemolytic index to indicate the effect of the UAV flight on the blood samples. The UAV was able to exceed 7 km of travel distance despite the relatively heavy load needed for the RBC solution storage. The LD level was not significantly different between the flight and non-flight (control) samples. However, we were not able to completely maintain a temperature of 2 °C to 6 °C; nonetheless, the deviation was within the safe range.

13 September 2021 in Drones
Verified
Journal Article
Open access
PDF file
KYKoki Yakushiji
Koki Yakushiji
FYFumiatsu Yakushiji
Fumiatsu Yakushiji
TYTakanori Yokochi
Takanori Yokochi
MMMikio Murata
Mikio Murata
MNMichiyo Nakahara
Michiyo Nakahara
HFHiroshi Fujita
Hiroshi Fujita
Long-distance transoceanic transport of blood using drones has never been reported. This study aimed to prove that blood transportation via drones can meet the rapid demand for blood transfusions anywhere in Japan, including remote islands. We demonstrated the transport of red blood cells (RBCs) packs using a drone over the sea from Sasebo to Arikawa port. Drone operations were conducted visually only at take-off and landing. Cruise flights were conducted via satellite-based remote control from Tokyo. The RBC solutions were transported at 2–6 °C to avoid hemolysis. Hemolysis was assessed visually and by measuring lactate dehydrogenase (LDH) levels before departure and upon arrival at Tokyo Metropolitan Bokutoh Hospital to evaluate whether RBCs were transfusable. LDH levels of the RBC solutions before and after transport were 57.5 ± 3.1 vs. 64.0 ± 2.9. RBC solutions were transported via air and land from Tokyo to Sasebo and showed no remarkable signs of hemolysis. Remote RBC solution transport by uncrewed helicopters with temperature control is feasible and allows RBC transportation in emergencies involving disrupted land transportation, such as the COVID-19 pandemic.

9 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KSKiyomi Sadamoto
Kiyomi Sadamoto
HUHiroyuki Ura
Hiroyuki Ura
MMMikio Murata
Mikio Murata
MHMasaho Hayashi
Masaho Hayashi
KKKiyoshi Kubota
Kiyoshi Kubota
Press-through packaging (PTP) is the most common type of drug packaging in Japan, and a production procedure for PTP has been established at an acceptable cost. However, unknown problems and new needs with regard to safety among users of various age-groups still need to be examined. Considering accident reports involving children and older adults, the safety and quality of PTP and new forms of PTP, such as child-resistant and senior-friendly (CRSF) packaging, should be evaluated. We conducted an ergonomic study on children and older adults to compare types of commonly used PTP and new varieties of PTP. Opening tests were attempted by children and older adults using a common type of PTP (Type A) and child-resistant (CR) PTP (Types B1 and B2) made from soft aluminum foil. The same opening test was conducted on older patients with rheumatoid arthritis (RA). The results showed that CR PTP was difficult for children to open: only 1 out of 18 children could open Type B1. On the other hand, all eight of the older adults could open Type B1, and eight patients with RA could easily open Types B1 and B2. These findings suggest that the quality of CRSF PTP can be improved with the use of new materials.

1 April 2017 in YAKUGAKU ZASSHI
Verified
Journal Article
Open access
MTMaho Taguchi
Maho Taguchi
MSMasato Shigeyama
Masato Shigeyama
NINahomi Ito
Nahomi Ito
NONoriko Ogawa
Noriko Ogawa
CTChisato Takahashi
Chisato Takahashi
HTHitomi Teramachi
Hitomi Teramachi
Mohs paste is an external preparation containing zinc hydrochloride and zinc oxide starch as the main ingredient, and it is used for the palliative treatment of patients with surgically untreatable malignant tumors. However, it has problems, such as changes in hardness and viscoelasticity with time and liquefaction by exudate. To overcome these problems, we modified the formulation of Mohs paste by excluding starch, which is the cause of physical changes, and investigated the base. In the modified Mohs paste using the macrogol ointment for the base, no marked change with time was noted in the hardness, malleability, or elongation property, and the water-absorbing properties were equivalent to those of Mohs paste immediately after preparation. The hardness did not decrease even after absorbing water. The drug release rate increased 1.5 times with the modified Mohs paste. Based on these findings, the risk of liquefaction-associated damage of the surrounding skin decreased on using the modified Mohs paste, and preparing in advance became possible. These results suggest that the modified Mohs paste using the macrogol ointment for the base exhibits an equivalent effect for control of exudate and a high effect for tissue fixation.